Open access
Oct 2026
Core needle biopsy-derived breast cancer microtumors enable functional drug-response testing for precision oncology
Summary To predict neoadjuvant chemotherapeutic outcomes, breast cancer organoids have been developed. However, low yields from small tissue specimens and the high cost of niche factor-enriched medium remain barriers to clinical translation. Here, breast cancer patient-derived microtumors (PDMs) from core needle biopsi...
Mooktapa Plikomol, Suphawat Laohawiriyakamol, Piyanun Wangkulangkul et al.
· iScience · 0 citations